Oregon Therapeutics SAS is a biotechnology company developing XCE853, an innovative Drug Candidate in Oncology:

Oregon Therapeutics SAS
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://oregon-therapeutics.com
Founded2018
Disease Focus
Development Stage
STOCK CODENon Listed
Address3 rue du Colonel Moll 75017 ParisFrance
3 rue du Colonel Moll 75017
Paris
France
Contact Number+33 1 34 29 47 77
+33 1 34 29 47 77
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]